Presence of mutation conferring resistance to lamivudine in plasma and cerebrospinal fluid of HIV-1 infected patients

The authors compared samples of cerebrospinal fluid (CSF) and plasma in which levels of HIV virus had been measured with samples from patients treated with lamivudine. They found a mutation which resists lamivudine in both CSF and plasma, which indicates that CSF and plasma HIV levels are related.